Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer
Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer
About this item
Full title
Author / Creator
Wang, Chenxing , Aikemu, Batuer , Shao, Yanfei , Zhang, Sen , Yang, Guang , Hong, Hiju , Huang, Ling , Jia, Hongtao , Yang, Xiao , Zheng, Minhua , Sun, Jing and Li, Jianwen
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Background The mTOR signaling pathway plays an important role in cancer. As a master regulator, the status of MTOR affects pathway activity and the efficacy of mTOR inhibitor therapy. However, little research has been performed to explore MTOR in colorectal cancer (CRC). Methods In this study, gene expression and clinical data were analyzed using T...
Alternative Titles
Full title
Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c0f24a0512dc4f0ba4ba09e8b2814c1b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c0f24a0512dc4f0ba4ba09e8b2814c1b
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/s12885-022-09901-w
